Objective To evaluate the efficacy and safety of netilmicin(NET) compared with amikacin(AMK) in the treatment of lower respiratory tract infections.

• 目的以阿米卡星为对照评价奈替米星治疗下呼吸道感染的临床有效性及安全性。